Andrei V. Reshetnickov

Andrei V. Reshetnickov

Auto-generated profile, based on publicly available information

Andrei V. Reshetnickov

Institute of Biomedical Chemistry (Russia)

Research Focus & Metrics

Academic Career Length

31Years (1996-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 December 2010 in Photodiagnosis and Photodynamic Therapy
Verified
Journal Article
Closed access
EKElena V. Kochneva
Elena V. Kochneva
EFElena V. Filonenko
Elena V. Filonenko
EVElena G. Vakulovskaya
Elena G. Vakulovskaya
ESElena G. Scherbakova
Elena G. Scherbakova
OSOleg V. Seliverstov
Oleg V. Seliverstov
ARAndrei V. Reshetnickov
Andrei V. Reshetnickov

29 March 2000
Verified
Conference Paper
Closed access
PDF file
AIAndrei V. Ivanov
Andrei V. Ivanov
ARAndrei V. Reshetnickov
Andrei V. Reshetnickov
GPGelii V. Ponomarev
Gelii V. Ponomarev
In vitro and in vivo biological evaluation of a novel drug substance 'photodithazine' has been performed. In vitro photocytotoxicity (EC50) was 1 (mu) M together with some cytotoxicity. In vivo acute toxicity has been found to be 170 mg/kg for KD10, 175 mg/kg for LD16, 197 mg/kg for LD50, 220 mg/kg for LD84 following 1 percent aqueous solution i.v. injection. Pharmacokinetics and biodistribution studies have been done using the same mice bearing inoculated under the skin of the flanks T36 embryocarcinomas injected i.v. with 40 mg/kg dose of the drug. Maximal tumor and most organs' uptake was attained 1 h.p.i., however, the drug's level in the organs rapidly decreasing to zero with the best tumor/muscle ratios over 10 by 5 h.p.i. 'Photodithazine' has been found to possess rapid clearance from the organism: 94 percent elimination 24 h.p.i. and 98 percent to 48 h.p.i. PDT has been performed in vivo involving 21-23 g A/Snell mice with the same type 0.9-1 g tumors injected 40 mg/kg drug i.p., with 670 nm light being delivered 5-6 h p.i. at different doses. The best irradiation dose has been found to be 170 J/cm2 with a sound necrotic effect and 1-3 week remission. Thus, 'Photodithazine' represents a potent photosensitizer for PDT.

1 February 2001 in Chemistry of Heterocyclic Compounds
Verified
Journal Article
Closed access
PDF file
ARA. V. Reshetnickov
A. V. Reshetnickov
TBT. A. Babushkina
T. A. Babushkina
GKG. V. Kirillova
G. V. Kirillova
GPG. V. Ponomarev
G. V. Ponomarev

29 March 2000
Verified
Conference Paper
Closed access
ARAndrei V. Reshetnickov
Andrei V. Reshetnickov
GPGelii V. Ponomarev
Gelii V. Ponomarev
OAOlga Yu. Abakumova
Olga Yu. Abakumova
TTTatyana A. Tsvetkova
Tatyana A. Tsvetkova
AKArtashes V. Karmenyan
Artashes V. Karmenyan
RBRudolf Ph. Baum
Rudolf Ph. Baum
Chlorine6 has been known to be attractive as photosensitizer (PS) for PDT for long. Its usefulness as a photosensitizing part of photoimmunotoxines for targeted PDT, as a synton for further chemical modification and as a promising PS has been widely recognized. There is a patented procedure at our disposal now allowing for preparation of a stable, well soluble and filtrating form of chlorine6- 'Photodithazine'. The elaborated production technology includes 4 steps. 'Photodithazine's 1-octanol/Phosphate buffer, pH 7.4 partition coefficient has been found to be 1.4, indicating that it must be able to localize in the plasma membrane. This may be a partial explanation of its higher photodynamic efficacy in vitro, comparing to 'Photosense' and its closeness to 'Photogem'.

1 June 2025 in ЗДОРОВЬЕ НАСЕЛЕНИЯ И СРЕДА ОБИТАНИЯ - ЗНиСО / PUBLIC HEALTH AND LIFE ENVIRONMENT
Verified
Journal Article
Closed access
PDF file
ARAndrei V. Reshetnickov
Andrei V. Reshetnickov
ТRТatyana V. Romanova
Тatyana V. Romanova
OAOlga P. Abaeva
Olga P. Abaeva
NPNadezhda Prisyazhnaya
Nadezhda Prisyazhnaya
Introduction: Public complaints to higher authorities serve as a dialogue between citizens and government agencies. Objective: Based on the comparative analysis of health care appeals from the regional population compiled with a fifteen-year time interval, to investigate the development of this feedback channel between the patient and the healthcare system and to establish the main reasons for health care complaints. Materials and methods: We examined and compared 4,536 health care appeals received by the Ministry of Health of the Nizhny Novgorod Region in 2005–2006 and 32,982 appeals received in 2020–2021. Results: In 2021, the numbers of appeals and complaints were 7.3 and 4.0 times higher than in 2006, respectively. The percentage of complaints to total appeals decreased from 8.5 % in 2006 to 4.6 % in 2021. The most frequent complaints were those of outpatient departments (34.3 % and 41.2 %) and health care quality (24.2 % and 22.6 %) in the years 2006 and 2021, respectively. Conclusions: The comparison of written health care appeals of the population filed with a fifteen-year time interval indicates the growing popularity of this feedback mechanism in communication between patients and health authorities. The proportion of complaints that are part of a total number of appeals increased but their reasons remained unchanged: health services in outpatient department (primary health care) and health care quality.

15 October 2025 in National Health Care (Russia)
Verified
Journal Article
Open access
PDF file
TST. V. Semenova
T. V. Semenova
ARA. V. Reshetnikov
A. V. Reshetnikov
ZSZh. M. Sizova
Zh. M. Sizova
NPNadezhda Prisyazhnaya
Nadezhda Prisyazhnaya
At present, ensuring high quality standards of professional training of doctors is one of the leading priorities for both the medical education system and the national health care system. And in this regard, the accreditation procedure acts as a mechanism of independent assessment of the quality of medical education and readiness of medical graduates to work independently, taking into account the requirements of practical healthcare. Aim. To study the level of satisfaction of medical specialists with the primary accreditation procedure and determine ways to improve it. Materials and methods. The study of accredited persons’ opinions about the procedure of primary accreditation was implemented in July-August 2024 on the basis of Sechenov University (online questionnaire survey, n = 17,058, 78 accreditation centers in the Russian Federation). Results. According to the data obtained, the majority of the study participants are satisfied with the primary accreditation procedure and believe that it improves the quality of medical services provided to patients, is an important process for assess ing and confirming the qualifications of medical specialists, motivates accredited persons to improve their knowledge and skills in their specialty, but contributes to an increase in the stress level of university graduates. The respondents’ satisfaction with the primary accreditation procedure was largely due to their high level of awareness (95.7 %) and readiness for accreditation tests: 31.4 % of accredited persons rated their readiness at 10 points (on a 10-point scale); 49.8 % chose the answer options “9 points” and “8 points”; 11.9 % believe that their level of readiness corresponded to 7 points. Only 5.9 % admitted that they were not sufficiently prepared for the accreditation tests (scores from 4 to 6 points), and 0.9 % indicated that they were practically unprepared for the initial accreditation (choice in the range of 1–3 points). Conclusion. The results of a comprehensive study of the satisfaction of medical specialists with the primary accreditation procedure indicate its importance as a tool for independent assessment of the quality of professional training, while potential areas for optimizing the organizational support of the accreditation process have been identified.